Acella Pharmaceuticals and Neuvosyn Laboratories have announced positive topline results from a phase 2 clinical trial of ...
Xeltis has announced successful results from its aXess EU phase 3 trial, confirming the potential of its restorative vascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback